Ravulizumab (genetical recombination) (300mg3ml/vial) 284vials,and 19 other contracts

Tender Notice

Tender Detail
Ravulizumab (genetical recombination) (300mg3ml/vial) 284vials,and 19 other contracts
Tendering Authority
Tender Category
Other
Publish Date
25 Feb 2026
Deadline
16 Apr 2026
Country
Japan
TenderNews Ref. No.
4470616260225-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients